Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
MGNX
#3184
MacroGenics, Inc.
1.9
9
+1.53%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
+1.53%
Monthly Change
+8.15%
6 month change
+13.71%
Cambio anual
-17.43%
Cierres anteriores
1.9
6
Open
1.9
9
Bid
Ask
Low
1.9
9
High
1.9
9
Volumen
16
Markets
Acciones
Atención Sanitaria
MGNX
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
56.26 M
61.32 M
61.84 M
62.43 M
63.09 M
—
Valuation ratios
Enterprise value
1.1 B
860.79 M
284.41 M
534.6 M
22.2 M
-71.3 M
Price to earnings ratio
—
-4.76
-3.26
-67.87
-3.04
-8.05
Price to sales ratio
—
12.42
2.57
10.73
1.36
3.17
Price to cash flow ratio
—
-6.69
-4.49
-8.06
-2.98
-5.83
Price to book ratio
—
4.02
2.75
4.13
1.75
2.52
Enterprise value to EBITDA ratio
—
37.36
2.8
34.06
0.26
-0.59
Profitability ratios
Return on assets %
0.34
0.6
0.43
0.03
0.26
0.02
Return on equity %
0.44
0.84
0.84
0.06
0.58
0.71
Return on invested capital %
338.26
510.33
323.56
442.07
386.54
—
Gross margin %
100
96.58
97.79
98.95
99.44
398.8
Operating margin %
124.96
261.85
79.91
286.38
73.74
226.96
EBITDA margin %
—
29.75
66.81
26.72
57.12
153.49
Net margin %
123.7
260.97
78.82
15.42
44.66
-5.08
Liquidity ratios
Quick ratio
—
3.69
4.54
4.46
3.92
17.07
Current ratio
6.17
3.75
4.57
4.48
3.92
17.68
Inventory turnover
—
0.6
1.15
0.46
1.39
0.14
Asset turnover
0.3
0.22
0.49
0.2
0.54
0.5
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
2.4
1.42
1.26
1.09
2.58
EBIT per share
—
0.2
1.46
0.1
1.25
1.1
EBITDA per share
—
0.38
1.65
0.25
1.37
1.22
Total debt per share
—
—
—
—
—
—
Cash per share
—
2.06
1.77
1.63
2.92
8.57
Net current asset value per share
—
4.66
3.62
4.06
3.47
13.28
Tangible book value per share
—
4
2.31
2.46
1.85
4.91
Working capital per share
—
3.42
2.83
3.15
2.59
10.19
Book value per share
—
4
2.31
2.46
1.85
4.91
Noticias
BioLife Solutions, Inc. (BLFS) Surpasses Q4 Earnings and Revenue Estimates
Las acciones de MacroGenics caen tras suspensión clínica parcial de la FDA
Acciones de MacroGenics caen tras suspensión clínica parcial de FDA
MacroGenics stock falls after FDA places partial clinical hold
Why Is MacroGenics Stock Sinking Tuesday? - Macrogenics (NASDAQ:MGNX)
Sanofi's Teizeild Gets EU Approval for Treating Type 1 Diabetes
FDA Accepts SNY Filing for Expanded Use of T1D Drug in Young Children
Thanksgiving: Top 10 Most Innovative BioPharma Drugs In Phase 3
MacroGenics (MGNX) Q3 Earnings and Revenues Surpass Estimates
MacroGenics Inc superaron 0.68$ las previsiones de BPA en el tercer trimestre del año
MacroGenics Inc supera por 0,68$ las previsiones de BPA en el tercer trimestre del año
MacroGenics Inc earnings beat by $0.68, revenue topped estimates